期刊文献+

siRNA干扰ERCC2表达对食管癌细胞紫杉醇敏感性的影响

ERCC2 expression in siRNA interference of esophageal cancer cells and correlation with paclitaxel sensitivity
下载PDF
导出
摘要 背景与目的:通过siRNA干扰沉默ERCC2基因,观察食管癌细胞株对紫杉醇敏感性的改变,初步探讨新的紫杉醇耐药可能机制。方法:体外合成靶向ERCC2的siRNA(si-ERCC2@;应用脂质体法瞬时转染ERCC2高表达细胞株KYSE150;应用RT-PCR和流式细胞术(FCM@分别检测转染组细胞ERCC2mRNA和蛋白的表达水平;应用MTT法检测转染前后细胞对紫杉醇敏感性的变化。结果:si-ERCC2组在转染后24、48、72h均未测出ERCC2特异性条带且ERCC2蛋白表达量分别下调了31.2%,51.6%和60.0%。si-ERCC2组紫杉醇IC50值为6.3±0.9μg/mL,较对照组降低49%。结论:siRNA成功封闭了目的基因ERCC2在转录和翻译水平的表达,封闭ERCC2表达能部分逆转紫杉醇耐药现象。 Background and purpose:ERCC2 gene silence by siRNA interference was observed in esophageal cancer cell line and it could change cell sensitivity to taxol.This study was to investigate the biological mechanism of paclitaxel-resistance in esophageal cancer cells.Methods:ERCC2 targeting siRNA(si-ERCC2)has been synthesized.The constructor were transfected into ERCC2 cell lines high-KYSE150(high expression of ERCC2)through lipofectamine.RT-PCR and flow cytometry(FCM)were used to detect the ERCC2 mRNA and protein expression levels.MTT assay was used to estimate the paclitaxel sensitivity of the cells.Results:In si-ERCC2 group,ERCC2 could not be detected and ERCC2 protein expression were reduced by 31.2%,51.6% and 60.0%,respectively,24,48,72 h after transfection.Paclitaxel IC50 value for si-ERCC2 group was 6.32 ± 0.87 μg/mL,lower than the control group(49%).Conclusion:siRNA could successfully silence the target gene ERCC2 at the level of transcription and translation of the gene,the reduction of ERCC2 expression may reverse taxol resistance of the cells.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2009年第10期761-765,共5页 China Oncology
基金 河北省自然科学基金(No:C2008000948)
关键词 食管癌细胞株 ERCC2 紫杉醇 IC50 siRNA esophageal carcinoma cell lines ERCC2 taxol IC50 siRNA
  • 相关文献

参考文献8

  • 1Shah MA, Schwartz GK. Cell cycle-mediated drug resistance an emerging concept in cancer therapy [ J ~ . Clin Cancer Res, 2001, 7(8): 2168-2181.
  • 2Merino C, Reynaud E, V a zquez M, et al. DNA Repair and transcriptional effects of mutations in TFIIH in drosophila development [ J ] . Mol Biol Cell, 2002, 13(9): 3246-3256.
  • 3Seker H, Butkiewicz D, Bowman ED, et al. Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid ceils with the XPD 312 Asp/Asp genotype [ J ] . Cancer Res, 2001, 61:7430-7434.
  • 4LeMorvan V, Bellott R, Moisan F, et al. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis- a -vis the NCI-60 panel [ J ] . Pharmacogenomics, 2006,7(6): 843-852.
  • 5陈忠平,Anne MONKS,Timothy G.MYERS,Edward A.SAUSVILLE,Dominic A.SCUDIERO,Lawrence C.PANASCI.人肿瘤细胞ERCC2基因表达与抗癌药耐药的相关性[J].中山医科大学学报,2001,22(3):170-173. 被引量:5
  • 6Rosell R, Taron M, Camps C, et al. Influence of genetic markers on survival in non-small cell lung cancer [ J ] . Drugs today(Barc), 2003, 39(10): 775-786.
  • 7Borkhardt A. Blocking oncogenes in malignant cells by RNA interference-new hope for a highly specific cancer treatment [ J ] .Cancer Ceil, 2002, 2(3): 167-168.
  • 8Sui G, Soohoo C, Afarel B, et al. A DNA vector based RNAi technology to suppress gene expression in mammalian cells [ J J. Proc Natl Acad Sci, 2002, 99(8): 5515-5520.

二级参考文献5

  • 1Chen Z P,Can J Neuro Sci,1999年,26卷,2期,104页
  • 2Chen Z P,Neurosurgery,1998年,42卷,5期,1112页
  • 3Sitaram A,Mol Cell Biol,1997年,17卷,2期,564页
  • 4Chen Z P,Mol Pharmacol,1997年,52卷,5期,815页
  • 5Chen Z P,Cancer Res,1996年,56卷,1期,2475页

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部